Pivotal Advance: CTLA-4+ T cells exhibit normal antiviral functions during acute viral infection

Journal of Leukocyte Biology

Volumn 81, Issue 5, 2007, Pages 1165-1175

  Raué, Hans Peter ^a   Slifka, Mark K ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

CD4; CD8; LCMV; Vaccinia

Indexed keywords

BROXURIDINE; CD28 ANTIGEN; CD3 ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; CELL ANTIBODY; CTLA4 ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; EFFECTOR CELL; EX VIVO STUDY; IMMUNE RESPONSE; IN VIVO STUDY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINIA; VACCINIA VIRUS; VIRUS INFECTION; VIRUS MENINGITIS;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; IMMUNOCONJUGATES; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; VACCINIA VIRUS;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; VACCINIA VIRUS;

EID: 34247868749     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0806535     Document Type: Article

References (51)

1. Lenschow, D. J., Walunas, T. L., Bluestone, J. A. (1996) CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233-258.
2. Chen, L. (2004) Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4, 336-347.
3. Kundig, T. M., Shahinian, A., Kawai, K., Mittrucker, H. W., Sebzda, E., Bachmann, M. F., Mak, T. W., Ohashi, P. S. (1996) Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 5, 41-52.
4. Kopf, M., Coyle, A. J., Schmitz, N., Barner, M., Oxenius, A., Gallimore, A., Gutierrez-Ramos, J. C., Bachmann, M. F. (2000) Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J. Exp. Med. 192, 53-62.
5. Andreasen, S. O., Christensen, J. E., Marker, O., Thomsen, A. R. (2000) Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses. J. Immunol. 164, 3689-3697.
6. Liu, Y., Wenger, R. H., Zhao, M., Nielsen, P. J. (1997) Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J. Exp. Med. 185, 251-262.
7. Shahinian, A., Pfeffer, K., Lee, K. P., Kundig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., Mak, T. W. (1993) Differential T cell costimulatory requirements in CD28-deficient mice. Science 261, 609-612.
8. Suresh, M., Whitmire, J. K., Harrington, L. E., Larsen, C. P., Pearson, T. C., Altman, J. D., Ahmed, R. (2001) Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory. J. Immunol. 167, 5565-5573.
9. Christensen, J. E., Christensen, J. P., Kristensen, N. N., Hansen, N. J., Stryhn, A., Thomsen, A. R. (2002) Role of CD28 co-stimulation in generation and maintenance of virus-specific T cells. Int. Immunol. 14, 701-711.
10. Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., Sharpe, A. H. (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547.
11. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., Mak, T. W. (1995) Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270, 985-988.
12. Chambers, C. A., Sullivan, T. J., Allison, J. P. (1997) Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation- dependent activation of CD4+ T cells. Immunity 7, 885-895.
13. Greenwald, R. J., Freeman, G. J., Sharpe, A. H. (2005) The B7 family revisited. Annu. Rev. Immunol. 23, 515-548.
14. Liu, Y. (1997) Is CTLA-4 a negative regulator for T-cell activation? Immunol. Today 18, 569-572.
15. Linsley, P. S., Greene, J. L., Tan, P., Bradshaw, J., Ledbetter, J. A., Anasetti, C., Damle, N. K. (1992) Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176, 1595-1604.
16. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., Bluestone, J. A. (1994) CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413.
17. Shrikant, P., Khoruts, A., Mescher, M. F. (1999) CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism. Immunity 11, 483-493.
18. Sotomayor, E. M., Borrello, I., Tubb, E., Allison, J. P., Levitsky, H. I. (1999) In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance. Proc. Natl. Acad. Sci. USA 96, 11476-11481.
19. Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., Ahmed, R. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682-687.
20. Waterhouse, P., Bachmann, M. F., Penninger, J. M., Ohashi, P. S., Mak, T. W. (1997) Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptor-transgenic CTLA-4-deficient mice. Eur. J. Immunol. 27, 1887-1892.
21. Chambers, C. A., Kuhns, M. S., Allison, J. P. (1999) Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses. Proc. Natl. Acad. Sci. USA 96, 8603-8608.
22. Bachmann, M. F., Kohler, G., Ecabert, B., Mak, T. W., Kopf, M. (1999) Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 163, 1128-1131.
23. Bachmann, M. F., Gallimore, A., Jones, E., Ecabert, B., Acha-Orbea, H., Kopf, M. (2001) Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered. Eur. J. Immunol. 31, 450-458.
24. Tivol, E. A., Gorski, J. (2002) Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4. J. Immunol. 169, 1852-1858.
25. Homann, D., Dummer, W., Wolfe, T., Rodrigo, E., Theofilopoulos, A. N., Oldstone, M. B., von Herrath, M. G. (2006) Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity. J. Virol. 80, 270-280.
26. Dummer, W., Ernst, B., LeRoy, E., Lee, D., Surh, C. (2001) Autologous regulation of naive T cell homeostasis within the T cell compartment. J. Immunol. 166, 2460-2468.
27. Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S., Bluestone, J. A. (1992) Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257, 789-792.
28. Harris, N. L., Peach, R. J., Ronchese, F. (1999) CTLA4-Ig inhibits optimal T helper 2 cell development but not protective immunity or memory response to Nippostrongylus brasiliensis. Eur. J. Immunol. 29, 311-316.
29. Ahmed, R., Salmi, A., Butler, L. D., Chiller, J. M., Oldstone, M. B. A. (1984) Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160, 521-540.
30. Raue, H. P., Brien, J. D., Hammarlund, E., Slifka, M. K. (2004) Activation of virus-specific CD8+ T cells by lipopolysaccharide-induced IL-12 and IL-18. J. Immunol. 173, 6873-6881.
31. Harrington, L. E., Most Rv, R., Whitton, J. L., Ahmed, R. (2002) Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope. J. Virol. 76, 3329-3337.
32. Slifka, M. K., Whitton, J. L. (2000) Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers. J. Immunol. 164, 208-216.
33. Gajewski, T. F., Fallarino, F., Fields, P. E., Rivas, F., Alegre, M. L. (2001) Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase. J. Immunol. 166, 3900-3907.
34. Egen, J. G., Kuhns, M. S., Allison, J. P. (2002) CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat. Immunol. 3, 611-618.
35. Kuhns, M. S., Epshteyn, V., Sobel, R. A., Allison, J. P. (2000) Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells. Proc. Natl. Acad. Sci. USA 97, 12711-12716.
36. Beadling, C., Slifka, M. K. (2005) Differential regulation of virus-specific T-cell effector functions following activation by peptide or innate cytokines. Blood 105, 1179-1186.
37. Gatta, L., Calviello, G., Di Nicuolo, F., Pace, L., Ubaldi, V., Doria, G., Pioli, C. (2002) Cytotoxic T lymphocyte-associated antigen-4 inhibits integrin-mediated stimulation. Immunology 107, 209-216.
38. Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., Ahmed, R. (1998) Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177-187.
39. Homann, D., Teyton, L., Oldstone, M. B. (2001) Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat. Med. 7, 913-919.
40. Slifka, M. K., Whitton, J. L. (2001) Functional avidity maturation of CD8+ T cells without selection of higher affinity TCR. Nat. Immunol. 2, 711-717.
41. Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C., Puccetti, P. (2002) CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3, 1097-1101.
42. Taylor, P. A., Lees, C. J., Fournier, S., Allison, J. P., Sharpe, A. H., Blazar, B. R. (2004) B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions. J. Immunol. 172, 34-39.
43. Chambers, C. A., Cado, D., Truong, T., Allison, J. P. (1997) Thymocyte development is normal in CTLA-4-deficient mice. Proc. Natl. Acad. Sci. USA 94, 9296-9301.
44. Cilio, C. M., Daws, M. R., Malashicheva, A., Sentman, C. L., Holmberg, D. (1998) Cytotoxic T lymphocyte antigen 4 is induced in the thymus upon in vivo activation and its blockade prevents anti-CD3-mediated depletion of thymocytes. J. Exp. Med. 188, 1239-1246.
45. Kwon, H., Jun, H. S., Khil, L. Y., Yoon, J. W. (2004) Role of CTLA-4 in the activation of single- and double-positive thymocytes. J. Immunol. 173, 6645-6653.
46. Walunas, T. L., Bakker, C. Y., Bluestone, J. A. (1996) CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183, 2541-2550.
47. Krummel, M. F., Allison, J. P. (1995) CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459-465.
48. Krummel, M. F., Allison, J. P. (1996) CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183, 2533-2540.
49. Metzger, H. (1992) Transmembrane signaling: the joy of aggregation. J. Immunol. 149, 1477-1487.
50. Yoon, S. T., Dianzani, U., Bottomly, K., Janeway Jr., C. A. (1994) Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity. Immunity 1, 563-569.
51. Madrenas, J., Chau, L. A., Teft, W. A., Wu, P. W., Jussif, J., Kasaian, M., Carreno, B. M., Ling, V. (2004) Conversion of CTLA-4 from inhibitor to activator of T cells with a bispecific tandem single-chain Fv ligand. J. Immunol. 172, 5948-5956.